Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)

This study has been completed.
Sponsor:
Collaborators:
Pharmacia
Amgen
Bristol-Myers Squibb
Information provided by (Responsible Party):
German Breast Group
ClinicalTrials.gov Identifier:
NCT00544232
First received: October 15, 2007
Last updated: February 12, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2006
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):